Sonoxone S 250mg/125mg Injection
Marketer
Sonika Life Sciences Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Sonoxone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; consistent adherence to the prescribed regimen is crucial, even with symptom improvement, as premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require immediate emergency care. Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your physician may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Sonoxone S 250mg/125mg Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Sonoxone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sonoxone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sonoxone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sonoxone S 250mg/125mg Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
How Sonoxone S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam Injection (Sonoxone S 250mg/125mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Sonoxone S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Sonoxone S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Sonoxone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Sonoxone S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Operation of a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sonoxone S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Sonoxone S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Sonoxone S 250mg/125mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Sonoxone S 250mg/125mg Injection :
Should you inadvertently skip a dose of Sonoxone S 250mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Sonoxone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently